| Trial ID: | L0252 |
| Source ID: | NCT00845845
|
| Associated Drug: |
Lovaza
|
| Title: |
Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)
|
| Acronym: |
--
|
| Status: |
Terminated
|
| Study Results: |
Has Results
|
| Results: |
https://ClinicalTrials.gov/show/NCT00845845/results
|
| Conditions: |
Nonalcoholic Steatohepatitis (NASH)|Hepatic Steatosis
|
| Interventions: |
Drug: Omega-3-acid ethyl esters (Lovaza)|Drug: Placebo
|
| Outcome Measures: |
Omega-3 Fatty Acid Supplementation and Its Effect on Hepatic Steatosis and Other Factors Associated With the Development of Nonalcoholic Steatohepatitis (NASH)|Magnetic Resonance Imaging (MRI) as an Assessment of Hepatic Steatosis in Patients With Biopsy-proven Nonalcoholic Steatohepatitis (NASH)
|
| Sponsor/Collaborators: |
University of Illinois at Chicago
|
| Gender: |
All
|
| Age: |
18 Years and older ?? (Adult, Older Adult)
|
| Phases: |
Phase 2
|
| Enrollment: |
12
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment
|
| Start Date: |
March 2006
|
| Completion Date: |
October 2010
|
| Results First Posted: |
July 24, 2013
|
| Last Update Posted: |
July 24, 2013
|
| Locations: |
The University of Illinois Chicago, Chicago, Illinois, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT00845845
|
